Monday, September 15, 2025
HomeIndustriesHealthcare

Healthcare

ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis

ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced consistent and significant blood pressure (“BP”) lowering results across a range...

NKGen Biotech Announces Collaboration with the Parkinson’s Foundation

NKGen Biotech, Inc., a biotechnology company harnessing the power of the body’s immune system through the development of natural killer (NK) cell therapies, announced...

Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

Telix Pharmaceuticals Limited announces highly positive top-line results from the pivotal Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational...

AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it has...

Bioretec Updates Its Estimate of the Timing for Approval of the CE Mark for the Remeos Trauma Screw

Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs trauma screw to be delayed from the original...
0FansLike
0FollowersFollow
spot_img

Hot Topics